Insider screener

Period: 12 months Role: Other officers × Plan: Scheduled (10b5-1) × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

10,618 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

10,618 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

10,618 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

10,618 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
10,618 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
10,618 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

10,618 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
29 Jun 2026
WALKER JOHN KENT President, Global Affairs, CLO · indirect
Sold on a plan 8×
$3.14M 8,998 at 349.29
10.7%
Planned (10b5-1)
29 Jun 2026
Lippoldt Darin Chief Legal Officer
Sold on a plan 2×
$1.67M 9,800 at 170.16
15.2%
Planned (10b5-1)
29 Jun 2026
Barton Shane Principal Accounting Officer
Sold on a plan
$1.07M 42,350 at 25.21
100%
Sold half or more
29 Jun 2026
Brannan Andrew EVP, Worldwide Sales
Sold on a plan
$935.41K 6,464 at 144.71
47.3%
Planned (10b5-1)
29 Jun 2026
Ye Gang COO · indirect
Sold on a plan 4×
$926.33K 10,000 at 92.63
1.7%
Planned (10b5-1)
29 Jun 2026
Lesage Anne Chief Early Development
Sold on a plan 2×
$371.69K 10,600 at 35.07
15.8%
Planned (10b5-1)
29 Jun 2026
Fendley Steven S. President, US Division
Sold on a plan
$338.56K 7,000 at 48.37
2.3%
Planned (10b5-1)
29 Jun 2026
Conrad Micah R. EVP & COO
Sold on a plan
$310.00K 5,000 at 62.00
4.9%
Planned (10b5-1)
29 Jun 2026
Bacos Anthony Chief Prod/Technology Officer
Sold on a plan 2×
$309.66K 70,011 at 4.42
6.2%
Planned (10b5-1)
29 Jun 2026
DUCHENE TODD M See remarks
Sold on a plan 3×
$261.66K 10,000 at 26.17
0.5%
Planned (10b5-1)
29 Jun 2026
Shah Rutul R Chief Operating Officer
Sold on a plan
$251.11K 42,924 at 5.85
7.9%
Planned (10b5-1)
29 Jun 2026
Clark Kyle SEE REMARKS · indirect
Sold on a plan
$245.75K 15,000 at 16.38
0.3%
Planned (10b5-1)
29 Jun 2026
Lesage Anne Chief Early Development · indirect
Sold on a plan
$245.23K 6,997 at 35.05
5.3%
Planned (10b5-1)
29 Jun 2026
Jamil Khurram Chief Medical Officer
Sold on a plan
$239.23K 47,467 at 5.04
100%
Sold half or more
29 Jun 2026
Barone Francesca Chief Scientific Officer
Sold on a plan
$235.77K 23,447 at 10.06
23.3%
Planned (10b5-1)
29 Jun 2026
Sold on a plan
$210.15K 7,500 at 28.02
22.2%
Planned (10b5-1)
29 Jun 2026
Katz Zachary CLO and Head of Global Affairs
Sold on a plan
$187.51K 12,799 at 14.65
1.7%
Planned (10b5-1)
29 Jun 2026
ten Bosch John Roderick SVP of Laboratory Operations
Sold on a plan
$169.92K 1,416 at 120.00
4.0%
Planned (10b5-1)
29 Jun 2026
Prahm Jeremy Chief Investment Officer
Sold on a plan
$152.02K 6,000 at 25.34
2.9%
Planned (10b5-1)
29 Jun 2026
Janku Filip Chief Medical Officer
Sold on a plan
$137.70K 6,000 at 22.95
9.1%
Planned (10b5-1)
29 Jun 2026
Khara Rahul Chief Legal Officer
Sold on a plan
$123.68K 1,649 at 75.00
3.1%
Planned (10b5-1)
29 Jun 2026
Zamora Javier General Counsel and Secretary
Sold on a plan
$120.37K 3,532 at 34.08
3.5%
Planned (10b5-1)
29 Jun 2026
Hedlund Michael A pao, SVP and Group Controller
Sold on a plan
$114.58K 1,848 at 62.00
12.3%
Planned (10b5-1)
29 Jun 2026
Lopresti Angelo P SVP, Secretary & Gen Counsel
Sold on a plan
$110.33K 1,000 at 110.33
1.6%
Planned (10b5-1)
29 Jun 2026
Camblong Jurgi Executive Chairman
Sold on a plan 2×
$108.06K 18,410 at 5.87
0.5%
Planned (10b5-1)
29 Jun 2026
Wang Yanjun CCO and GC · indirect
Sold on a plan 4×
$92.59K 1,000 at 92.59
2.0%
Planned (10b5-1)
29 Jun 2026
Everett Andrew H II Sr. VP, General Counsel & Secy
Sold on a plan
$84.94K 10,565 at 8.04
3.7%
Planned (10b5-1)
29 Jun 2026
Frangou Angeliki See Remarks · indirect
Bought on a plan
$83.20K 1,208 at 68.88
0.0%
Bought on a plan
29 Jun 2026
Shaikhly Samira Chief People Officer
Sold on a plan
$76.62K 2,178 at 35.18
73.3%
Sold half or more
29 Jun 2026
Tyagarajan Seshu Chief Technology Officer
Sold on a plan
$70.15K 7,000 at 10.02
7.7%
Planned (10b5-1)
29 Jun 2026
Eltoukhy Adam SEE REMARKS
Sold on a plan
$65.41K 2,039 at 32.08
0.5%
Planned (10b5-1)
29 Jun 2026
Mikael Cho Senior Vice President
Sold on a plan
$56.03K 59,604 at 0.94
32.9%
Planned (10b5-1)
29 Jun 2026
Gracey Craig Chief Accounting Officer
Sold on a plan
$43.74K 2,083 at 21.00
70.8%
Sold half or more
29 Jun 2026
Shams Sammaad Chief Accounting Officer
Sold on a plan
$35.78K 2,006 at 17.84
2.7%
Planned (10b5-1)
29 Jun 2026
Mikael Cho Senior Vice President · indirect
Sold on a plan
$31.15K 33,143 at 0.94
16.9%
Planned (10b5-1)
29 Jun 2026
Bliss Kelly President, U.S. Group Health
Sold on a plan
$21.25K 2,500 at 8.50
2.7%
Planned (10b5-1)
29 Jun 2026
Islam Nayaab See Remarks
Sold on a plan
$16.90K 1,300 at 13.00
0.0%
Planned (10b5-1)
29 Jun 2026
GALLAGHER JOHN R Chief Operating Officer
Sold on a plan
$10.93K 431 at 25.35
1.3%
Planned (10b5-1)
29 Jun 2026
Rosenberg Nick Executive Vice President
Sold on a plan
$9.00K 90 at 100.06
0.4%
Planned (10b5-1)
29 Jun 2026
Streams Mark See Remarks
Sold on a plan
$3.90K 300 at 13.00
0.0%
Planned (10b5-1)
26 Jun 2026
Linford Michael Chief Operating Officer
Sold on a plan
$8.00M 100,000 at 80.04
45.9%
Planned (10b5-1)
26 Jun 2026
Blecharczyk Nathan Chief Strategy Officer · indirect
Sold on a plan 3×
$4.54M 31,033 at 146.43
28.6%
Planned (10b5-1)
26 Jun 2026
KERBER ERIN J Chief Legal Officer
Sold on a plan 8×
$3.60M 5,720 at 629.80
18.2%
Planned (10b5-1)
26 Jun 2026
Warren Eric Chief Commercial Officer
Sold on a plan
$2.70M 104,124 at 25.90
73.1%
Sold half or more
26 Jun 2026
Hancock Mark Co Fndr; Exec V Chair
Sold on a plan 2×
$2.51M 61,931 at 40.50
0.1%
Planned (10b5-1)
26 Jun 2026
Schneider Eugene EVP, Chf Clinical Develop Ofcr
Sold on a plan
$2.11M 26,000 at 81.05
25.2%
Planned (10b5-1)
26 Jun 2026
Rosa Luvizotto Glauber Chief Operating Officer
Sold on a plan
$1.46M 22,367 at 65.27
5.2%
Planned (10b5-1)
26 Jun 2026
Elliott Nicholas J Chief Transformation Officer
Sold on a plan 8×
$1.45M 2,306 at 629.99
9.9%
Planned (10b5-1)
26 Jun 2026
Sold on a plan
$1.03M 28,623 at 36.02
0.7%
Planned (10b5-1)
26 Jun 2026
ONeill Francis James Co-Founder, Chief U/W Officer · indirect
Sold on a plan
$968.90K 73,500 at 13.18
1.1%
Planned (10b5-1)
Showing 3,301–3,350 of 10,618. ← Newer Page 67 of 213 Older →